🇺🇸 FDA
Patent

US 9885018

High efficiency reprogramming of fibroblasts into cardiomyocytes

granted A61KA61K31/713A61K38/1709

Quick answer

US patent 9885018 (High efficiency reprogramming of fibroblasts into cardiomyocytes) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/713, A61K38/1709, A61K45/06, A61K48/00